Hypericin photodynamic therapy in healthy volunteers.

Trial Profile

Hypericin photodynamic therapy in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Hypericin (Primary)
  • Indications Cutaneous T cell lymphoma; Psoriasis
  • Focus Adverse reactions
  • Sponsors HY BIOPHARMA
  • Most Recent Events

    • 16 Sep 2014 New trial record
    • 05 Sep 2014 Results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top